The S&P 500 soared more than 32% in 2013, and several big pharma companies, namely Bristol-Myers Squibb (NYSE:BMY), AbbVie (NYSE:ABBV), Roche (OTC:RHHBY), Johnson & Johnson (NYSE:JNJ), and AstraZeneca (NASDAQ:AZN) also performed extraordinarily well. The following slideshow reveals why these companies beat out their big pharma peers and what drove their strong performances in 2013.
Motley Fool Returns
Discounted offers are only available to new members. Stock Advisor will renew at the then current list price. Stock Advisor list price is $199 per year.
Stock Advisor launched in February of 2002. Returns as of 09/21/2021.
Average returns of all recommendations since inception. Cost basis and return based on previous market day close.